The Goldman Sachs Group, Inc. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-08 1:53 pm Sale | 2026-03-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | THE GOLDMAN SACHS GROUP, INC. GS | 128,862 0.500% | -1,635,986 (-92.70%) | Filing |
| 2026-02-12 10:33 am Purchase | 2025-12-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | THE GOLDMAN SACHS GROUP, INC. GS | 1,764,848 6.300% | 1,764,848 (New Position) | Filing |